Desvenlafaxine: First-Line Antidepressant for Menopause
Desvenlafaxine: A Potential First-Line Antidepressant and Its Specific Relevance for Menopause Major depressive disorder affects millions globally, but …
-
-
Desvenlafaxine: First-Line Treatment for Menopausal Cognitive Dysfunction
Desvenlafaxine Identified as a Potential First-Line Treatment for Menopausal Cognitive Dysfunction A recent international review, convened by psychiatri…
-
Bioidentical Hormones Research on Doctors’ Decisions
Bioidentical Hormones for Menopause: What Research on Doctors’ Decisions Reveals A new survey of 600 obstetricians and gynecologists in Turkey examined …
-
Young Breast Cancer Survivors Face Menopause and Cognitive Effects
Introduction A recent review from Scuola Superiore Meridionale and Italy’s IRCCS Istituto Nazionale Tumori outlines the complex challenges faced by youn…
-
Breast Cancer, Early Menopause, and Brain Fog
Introduction For a growing number of women, the cognitive changes labeled “brain fog” are far more than a transient nuisance of natural menopause
-
Menopause Brain Fog Impacts Breast Cancer Survivors Cognition
Menopause Brain Fog: The Tangible Link to Long-Term Cognition After Breast Cancer An Italian-led research review from the Scuola Superiore Meridionale a…
-
Menopause Brain Health: Alzheimer’s Risk & 2026 Studies
Introduction Menopause is the single greatest risk factor for developing Alzheimer’s disease
-
Young Breast Cancer Survivors Face Menopause Challenges
Introduction A 2026 review in Frontiers in Oncology from the IRCCS Istituto Nazionale Tumori “Fondazione G
-
Postmenopause Increases Cognitive Risk, Memory Most Affected
Postmenopause May Bring Significant Cognitive Risk, with Memory Most Affected Nearly 80% of postmenopausal women in a recent Indian study showed signs o…
-
Breast Cancer, Treatment Menopause & Cognitive Function Review
Introduction Young women who experience treatment-induced menopause following breast cancer face a distinct set of cognitive challenges